Open
Episode cover
YouTube21 Aug 2024
9m

BSV Deal Is Approx ₹14,000 Cr & We Intend To Fund ₹4,000 Cr Via Internal Accruals: Mankind Pharma

Podcast cover

CNBC-TV18

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

BSV Deal Is Approx ₹14,000 Cr & We Intend To Fund ₹4,000 Cr Via Internal Accruals: Mankind Pharma